David Ting
Co-Director & Director - Biomarker Discovery Lab &Tumor Cartography Center, Clinical Innovation Mass General Brigham Cancer Institute & Harvard Medical School
Seminars
Wednesday 7th October 2026
From Spatial Discovery to Clinical Deployment: Building a Multiplex Biomarker Assay for Pancreatic Cancer Research
12:10 pm
- High-plex spatial transcriptomics as a discovery engine to reveal disease biology and prioritize biomarker candidates
- A structured path from high-plex signals to a focused low-plex assay using reproducible multiplex IHC/RNA-ISH development
- Patient stratification for pharma partners built on tumor cell state and molecular characterization
